Views: 15<\/p>
Recently the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) jointly have issued clinical recommendations on the proper treatment of hospitalized patients with high blood glucose levels.<\/p>\n
For critically ill patients<\/strong>: For non-critically ill patients<\/strong>: Views: 15Recently the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) jointly have issued clinical recommendations on the proper treatment of<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[257,3],"tags":[83,75,78,77,74,81,76,82],"class_list":["post-78","post","type-post","status-publish","format-standard","hentry","category-daily","category-general","tag-critically-ill-patient","tag-diabetes","tag-glucose","tag-glycaemic","tag-high-blood-glucose-level","tag-hospitalized-patient","tag-insulin-therapy","tag-sliding-scale"],"_links":{"self":[{"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/posts\/78","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/comments?post=78"}],"version-history":[{"count":6,"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/posts\/78\/revisions"}],"predecessor-version":[{"id":364,"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/posts\/78\/revisions\/364"}],"wp:attachment":[{"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/media?parent=78"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/categories?post=78"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rajib.info\/blog\/wp-json\/wp\/v2\/tags?post=78"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u2022 For treatment of persistent hyperglycemia, beginning at a threshold of no greater than 180 mg\/dL (10.0 mmol\/L), insulin therapy should be started.
\n\u2022 For most critically ill patients, glucose level between 140 to 180 mg\/dL (7.8 – 10.0 mmol\/L) is recommended once insulin therapy has been started.
\n\u2022 Continuous intravenous insulin infusions are preferred to achieve and maintain the glycaemic control in critically ill patients.
\n\u2022 Validated insulin infusion protocols that are shown to be safe and effective and to have low rates of hypoglycemia are recommended.
\n\u2022 Frequent glucose monitoring is essential for the patients receiving intravenous insulin to reduce hypoglycemia and to achieve optimal glucose control.<\/p>\n
\n\u2022 For most non-critically ill patients receiving insulin therapy, targets\u00a0 if can be safely achieved should be-
\nFBS (Fasting blood glucose) level < 140 mg\/dL (< 7.8 mmol\/L), and
\nRBS (Random blood glucose) level < 180 mg\/dL (< 10.0 mmol\/L).
\n\u2022 More rigorous targets may be appropriate in stable patients in whom tight glycaemic control was previously achieved.
\n\u2022 Less stringent targets may be appropriate in terminally ill patients or in those with severe co-morbidities.
\n\u2022 For achieving and maintaining glycaemic control, the preferred method is scheduled subcutaneous administration of insulin, with basal, nutritional, and correction components.
\n\u2022 As the only therapeutic agent, prolonged treatment with sliding-scale insulin is discouraged.
\n\u2022 For most hospitalized patients who require the treatment of hyperglycemia, non-insulin anti-hyperglycemic agents are not appropriate.
\n\u2022 Day-to-day decisions concerning treatment of hyperglycemia must be based on clinical judgment and ongoing evaluation of clinical status.<\/p>\n","protected":false},"excerpt":{"rendered":"